BluePill prices synthetic respondents at $10 each

BluePill opened a marketplace of more than 1,000 AI consumer twins at $10 per twin per study, each grounded in an interview with a real U.S. breakfast buyer, according to the company’s launch announcement. The first study is free; the company reports a 0.91 Spearman correlation against live-panel MaxDiff responses, but that validation remains vendor-reported. Research teams should use the marketplace to widen cheap, early concept exploration—not replace human panels—until independent tests show the twins survive the same provenance and detection scrutiny described in the rising cost of verifying synthetic content.